KOD

Kodiak Sciences Inc.

NasdaqHealthcareBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Insider activity for last month from Oct 16 to Nov 16.

How these metrics are calculated

Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Total buying$24.3M4 buys
Total selling$2.70M8 sales
Net open-market+$21.6MBuying minus selling
Active insiders8Distinct reporting owners

KOD transaction history

Newest filings · 20 transactions per page

Latest insider transactions

Form 4 filings from last month.
Newest company filings
InsiderActivityDisclosed valueFiled (ET)
BAKER BROS. ADVISORS LP
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+3
Large buy

A buy above $1.0M, or above twice the company’s median insider trade with at least three prior trades in the sample.

Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$8.05MView disclosure →
BAKER BROS. ADVISORS LP
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$463kView disclosure →
BAKER BROS. ADVISORS LP
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+3
Large buy

A buy above $1.0M, or above twice the company’s median insider trade with at least three prior trades in the sample.

Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$15.0MView disclosure →
BAKER BROS. ADVISORS LP
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Large buy

A buy above $1.0M, or above twice the company’s median insider trade with at least three prior trades in the sample.

Director buy

The buyer is identified as a director.

SEC filing ↗
$861kView disclosure →
Yang Taiyin
Director
DIR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Large disposal
Units disposed were at least 25% of reported post-transaction holdings.
Derivative securitySEC filing ↗
$0View disclosure →
Yang Taiyin
Director
DIR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Large acquisition
Units acquired were at least 25% of reported post-transaction holdings.
SEC filing ↗
$47.0kView disclosure →
Borgeson John A.
Chief Financial Officer
CFO
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
Derivative securitySEC filing ↗
$0View disclosure →
Borgeson John A.
Chief Financial Officer
CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Repeat seller
The same owner reported more than one sale within 30 days.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
−$9.49kView disclosure →
Borgeson John A.
Chief Financial Officer
CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Repeat seller
The same owner reported more than one sale within 30 days.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
−$187kView disclosure →
Borgeson John A.
Chief Financial Officer
CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Repeat seller
The same owner reported more than one sale within 30 days.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
−$185kView disclosure →
Borgeson John A.
Chief Financial Officer
CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Repeat seller
The same owner reported more than one sale within 30 days.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
−$274kView disclosure →
Borgeson John A.
Chief Financial Officer
CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Repeat seller
The same owner reported more than one sale within 30 days.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
−$464kView disclosure →
Borgeson John A.
Chief Financial Officer
CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Repeat seller
The same owner reported more than one sale within 30 days.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
−$684kView disclosure →
Borgeson John A.
Chief Financial Officer
CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Repeat seller
The same owner reported more than one sale within 30 days.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
−$150kView disclosure →
Borgeson John A.
Chief Financial Officer
CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
−$746kView disclosure →
Borgeson John A.
Chief Financial Officer
CFO
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
$74.7kView disclosure →

Insider activity report

Calendar-month buckets within the selected date range

Latest filing: Nov 6, 2026

Open-market transaction mix · 12 transactions in the selected period
4 buys33%·67%8 sells

Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.

View exact monthly counts and disclosed values
Monthly activity within the selected period; unknown values remain unknown.
MonthBuysSellsAwards (A)Buy valueSell valueNet P/S value
Oct 2026080$0$2,700,322.38−$2,700,322.38
Nov 2026400$24,340,835.90$0+$24,340,835.90

Distinct insiders active

Reporting-owner CIKs by month · peak Nov 2026 (6)
Oct 2026: 2 insidersNov 2026: 6 insiders
Oct 2026Nov 2026
8distinct insiders in selected period
Largest insider activity
By absolute net disclosed value · current transaction page
3 insiders
Filing, role and holdings details
Recent filing activity
Most recent 6 transactions on this page · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy$15.0M
Largest sale$746k
10b5-1 detected10
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
16transactionstxns
  • S · Open-market sells · dominant8 · 50%
  • M · Option exercise4 · 25%
  • P · Open-market buys4 · 25%

Activity by reported role

A joint filing can contribute to multiple roles
Chief financial officer10
Director6

Reported Holdings After

Separated by insider, security, and ownership type

Borgeson John A.Common Stock · Direct
242k212kOct 21, 2026Oct 21, 2026
211,930Oct 21, 2026
Baker JulianCommon Stock · Indirect · See Footnotes
20.4M1.68MNov 4, 2026Nov 5, 2026
20,424,859Nov 5, 2026
Baker FelixCommon Stock · Indirect · See Footnotes
20.4M1.68MNov 4, 2026Nov 5, 2026
20,424,859Nov 5, 2026
BAKER BROS. ADVISORS LPCommon Stock · Indirect · See Footnotes
20.4M1.68MNov 4, 2026Nov 5, 2026
20,424,859Nov 5, 2026
667, L.P.Common Stock · Indirect · See Footnotes
20.4M1.68MNov 4, 2026Nov 5, 2026
20,424,859Nov 5, 2026
Borgeson John A.Stock Option (Right to Buy) · Direct
305k305kOct 21, 2026Oct 21, 2026
304,500Oct 21, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells red
3 active days
Oct 16 → Nov 16
LessMore

Kodiak Sciences Inc. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at Kodiak Sciences Inc.?

667, L.P., Baker Bros. Advisors (GP) LLC, BAKER BROS. ADVISORS LP, Baker Brothers Life Sciences LP, BAKER FELIX, BAKER JULIAN, Yang Taiyin, BORGESON JOHN A..

When was the latest reported open-market purchase?

BAKER BROS. ADVISORS LP reported a buy on Nov 5, 2026 valued at $8.05M. Read the SEC filing.

When was the latest reported open-market sale?

Borgeson John A. reported a sale on Oct 21, 2026 valued at $9.49k. Read the SEC filing.

What is the recent purchase and sale balance?

Net open-market buying in the selected period was $21,640,513.52.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.